Abstract
Recent studies have demonstrated that there are differences among races in efficacy, tolerance and other outcomes in oncologic care. Some of these differences may be explained by different pharmacogenetics; however, social and environmental factors that can affect oncology practice are relatively underestimated. In this review we will focus on differences in environment, education and research between Japan and the US when it comes to lung cancer clinical practice. Such social differences seem to derive from historical reasons and continue to influence clinicians and researchers who manage lung cancer. Understanding the differences might help us conduct collaborative research in the future.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3804-3808 |
| Number of pages | 5 |
| Journal | Journal of Thoracic Disease |
| Volume | 12 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 1 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Pulmonary and Respiratory Medicine
Fingerprint
Dive into the research topics of 'Difference of environment behind research and clinical practice between USA and Japan'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver